Telegram RegisterThe public register of Telegram
Telegram profile photo for 바이오 뉴우스

Channel

바이오 뉴우스

@biotherapy777

On this record: Topic · Growth · Engagement · Posts · Cite this entry

83subscribers

+0 since we began measuring on 8 August 2026

Risers and fallers across the register · movement among entries of Under 1,000.

Register entry

Telegram ID-1001368713590
TypeChannel
Username@biotherapy777
CreatedBetween 1 April 2018 and 31 August 2021 — estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded9 August 2026
Last confirmed live8 October 2026
Measurements held4
Confirmed unchanged2 times, most recently 8 October 2026
On Telegramt.me/biotherapy777

Topic

Health & wellness — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-FP8, prompt version 1) read this channel’s own recent posts on 27 September 2026 and assigned it the closest of 31 fixed categories, at 81% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and why it has no browse page of its own yet.

Growth

828382.58 August 2026 — 83 subscribers9 August 2026 — 83 subscribers23 August 2026 — 82 subscribers29 September 2026 — 83 subscribers8 August 202629 September 2026
4 measurements spanning 52 days. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 82–83 and does not start at zero.
Measurement log — every subscribers count we have recorded
Measured (UTC)SubscribersChange
29 Sept 2026, 01:2083+1
23 Aug 2026, 19:5882-1
9 Aug 2026, 17:4683no change
8 Aug 2026, 02:4883first reading

Engagement

20 posts held, back to 29 October 2024 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.

Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 29 October 2024. An engagement rate over an empty window would be a number about nothing.

Recent posts

29 Oct 2024, 23:23 UTC115 viewsread 9 August 2026

메디웨일, 국제의료영상처리학회 의료AI 대회서 1위 수상 - 한스경제 https://ift.tt/mGMrUPz

29 Oct 2024, 22:48 UTC117 viewsread 9 August 2026

노인성 황반변성 주사제 ‘아일리아’…삼성에피스 등 시밀러 약진 - 이코노믹리뷰 https://ift.tt/vlyKbVY

29 Oct 2024, 22:48 UTC117 viewsread 9 August 2026

[인터뷰] “치매 신약 레켐비, 두 번 실패 끝 탄생…안전성 우려 해소될 것” - 조선비즈 - 조선비즈 https://ift.tt/RwUTf5V

29 Oct 2024, 22:48 UTC117 viewsread 9 August 2026

에자이, 치매 신약 '레켐비' 병용 타우 타깃 'E2814' 2상 개시 - 네이트 뉴스 https://ift.tt/7eqFjgr

29 Oct 2024, 22:23 UTC114 viewsread 9 August 2026

에자이, 치매 신약 '레켐비' 병용 타우 타깃 'E2814' 2상 개시 - 네이트 뉴스 https://ift.tt/7eqFjgr

29 Oct 2024, 22:18 UTC109 viewsread 9 August 2026

[인터뷰] “치매 신약 레켐비, 두 번 실패 끝 탄생…안전성 우려 해소될 것” - 조선비즈 https://ift.tt/2BlYO5s

29 Oct 2024, 22:18 UTC105 viewsread 9 August 2026

코야 테라퓨틱스, 알츠하이머병 임상 2상서 긍정적 결과 - 메디소비자뉴스 https://ift.tt/kDz7Lqx

29 Oct 2024, 22:18 UTC97 viewsread 9 August 2026

에자이, 치매 신약 '레켐비' 병용 타우 타깃 'E2814' 2상 개시 - 네이트 뉴스 https://ift.tt/WJBQ9Xk

29 Oct 2024, 22:13 UTC83 viewsread 9 August 2026

[인터뷰] “치매 신약 레켐비, 두 번 실패 끝 탄생…안전성 우려 해소될 것” - 조선비즈 - 조선비즈 https://ift.tt/RwUTf5V

29 Oct 2024, 22:13 UTC66 viewsread 9 August 2026

에자이, 치매 신약 '레켐비' 병용 타우 타깃 'E2814' 2상 개시 - 네이트 뉴스 https://ift.tt/WJBQ9Xk

29 Oct 2024, 21:58 UTC52 viewsread 9 August 2026

코야 테라퓨틱스, 알츠하이머병 임상 2상서 긍정적 결과 - 메디소비자뉴스 https://ift.tt/kDz7Lqx

29 Oct 2024, 21:18 UTC45 viewsread 9 August 2026

더블유앤피바이오, ‘뉴클레오스킨’ 국내 독점 총판 - 청년의사 https://ift.tt/yL6JbOi

Showing the 12 most recent of 20 posts we hold for @biotherapy777. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 29 September 2026 — this entry's latest reading, not the date you are reading this.

“바이오 뉴우스” (@biotherapy777), 83 subscribers as measured 29 September 2026. Telegram Register, tgregister.com/channel/biotherapy777.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.